GlassScriptPhysician profile
Eric J Greene
NPI 1508225640
$2,253.14
in general payments reported to CMS, 2019-2025
21 companies · $389 in 2025
The $389 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $80.01 · 2022: $904 · 2023: $400 · 2024: $481 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,269.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $568.39 | 2022-2025 | Azstarys |
| Medacta USA, INC. | $546.79 | 2022 | |
| Ironshore Pharmaceuticals INC. | $211.94 | 2022-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $166.90 | 2022-2025 | Gardasil 9, Vaxneuvance, Proquad |
| Collegium Pharmaceutical, INC. | $106.82 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $89.75 | 2023-2025 | |
| Cranial Technologies, INC | $72.98 | 2023-2025 | Doc Band |
| Alk-Abello, INC | $72.10 | 2025 | Neffy |
| Hologic Sales and Service, LLC | $59.83 | 2023-2024 | Aptima, Affirm Prone Biopsy System |
| Glaxosmithkline, LLC. | $55.89 | 2021-2023 | Bexsero |
| Kaleo, INC. | $50.56 | 2023-2024 | Auvi-Q |
| Sanofi-Aventis U.S. LLC | $48.39 | 2023-2025 | |
| Seqirus USA INC | $45.56 | 2025 | Flucelvax |
| Neos Therapeutics, LP | $35.10 | 2021-2022 | |
| Biogen, INC. | $22.11 | 2023 | Spinraza |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $19.92 | 2021 | |
| Biomerieux INC | $19.65 | 2025 | |
| Pfizer INC. | $17.36 | 2024 | |
| Sobi, INC | $16.61 | 2022 | |
| Supernus Pharmaceuticals, INC. | $14.61 | 2021 | |
| Aytu Biopharma, INC. | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Greene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.